Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pregabalin for painful diabetic neuropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Diabetic Neuropathy, Painful | Phase 4 | Status: COMPLETED